发明名称 Human anti-b7rp1 neutralizing antibodies
摘要 Disclosed is an antibody that binds specifically to B7RP1 wherein the antibody, or an antigen-binding or an immunologically functional immunoglobulin fragment thereof, comprises a light chain comprising a CDR1 sequence as set forth in SEQ ID NO: 18 (RASQSVSSYLA) and a light chain comprising a CDR2 sequence as set forth in SEQ ID NO: 19 (DASNRAT), the antibody or the fragment thereof further comprising: (a) a heavy chain CDR1 sequence as set forth in SEQ ID NO: 30 (SYGMH), a heavy chain CDR2 sequence as set forth in SEQ ID NO: 31 (VIWYDGSKKYYADSVEG), a heavy chain CDR3 sequence as set forth in SEQ ID NO: 32 (DLNIMVWGIFDY), and a light chain CDR3 sequence as set forth in SEQ ID NO: 20 (QQRNNWPWT); or (b) a heavy chain CDR1 sequence as set forth in SEQ ID NO: 35 (SYAMH), a heavy chain CDR2 sequence as set forth in SEQ ID NO: 36 (AIGTGGGTYYADSVKG), a heavy chain CDR3 sequence as set forth in SEQ ID NO: 37 (GVPLLWFGEFY), and a light chain CDR3 sequence as set forth in SEQ ID NO: 23 (QQRSNWPALT); wherein the antibody or the fragment thereof inhibits B7RP1 activity.
申请公布号 NZ625807(A) 申请公布日期 2015.11.27
申请号 NZ20060625807 申请日期 2006.07.18
申请人 AMGEN INC.;MEDAREX L.L.C. 发明人 HUANG HAICHUN;SHEN WENYAN;SIU GERALD;YOSHINAGA STEVEN KIYOSHI
分类号 A61K39/395;A61P11/06;A61P37/00;C07K16/28;C12N5/10;C12N15/13;G01N33/577;G01N33/68 主分类号 A61K39/395
代理机构 代理人
主权项
地址